Mann Ritse M, Longo Valentina
Department of Imaging, Radboud University Medical Center, Nijmegen, the Netherlands; Department of Radiology, the Netherlands Cancer Institute, Amsterdam, the Netherlands.
Department of Bioimaging, Radiation Oncology and Hematology, UOC of Radiodiagnostica Presidio Columbus, Fondazione Policlinico Universitario A. Gemelli IRCSS, Largo A. Gemelli 8, Rome 00168, Italy.
Radiol Clin North Am. 2024 Jul;62(4):643-659. doi: 10.1016/j.rcl.2024.02.003. Epub 2024 Mar 11.
Breast MR imaging and contrast-enhanced mammography (CEM) are both techniques that employ intravenously injected contrast agent to assess breast lesions. This approach is associated with a very high sensitivity for malignant lesions that typically exhibit rapid enhancement due to the leakiness of neovasculature. CEM may be readily available at the breast imaging department and can be performed on the spot. Breast MR imaging provides stronger enhancement than the x-ray-based techniques and offers higher sensitivity. From a patient perspective, both modalities have their benefits and downsides; thus, patient preference could also play a role in the selection of the imaging technique.
乳腺磁共振成像(MRI)和对比增强乳腺X线摄影(CEM)都是通过静脉注射造影剂来评估乳腺病变的技术。这种方法对恶性病变具有很高的敏感性,由于新生血管的渗漏,恶性病变通常表现为快速强化。CEM在乳腺影像科可能很容易获得,并且可以当场进行。乳腺MRI比基于X线的技术提供更强的强化,并且具有更高的敏感性。从患者的角度来看,这两种检查方式都有其优点和缺点;因此,患者的偏好也可能在成像技术的选择中起作用。